| A multicenter retrospective chart review study of treatment and disease patterns and clinical outcomes of patients with chronic-phase chronic myeloid leukemia in third-line … FE Nicolini, F Huguet, L Huynh, C Xu, C Bouvier, A Yocolly, G Etienne Cancers 15 (16), 4161, 2023 | 1 | 2023 |
| Treatment Patterns, Tolerance, and Clinical Response of Chronic Phase Chronic Myeloid Leukemia (CML-CP) Patients (Including Those Harboring the T315I Mutation) Experiencing … FE Nicolini, F Huguet, L Huynh, C Xu, C Bouvier, A Yocolly, G Etienne Blood 140 (Supplement 1), 9656-9658, 2022 | 1 | 2022 |
| A Web-based tool for quantification of potential gains in life expectancy by preventing cause-specific mortality A Chandran, C Xu, J Gross, KM Leifheit, D Phelan-Emrick, S Helleringer, ... Frontiers in Public Health 9, 663825, 2021 | 1 | 2021 |
| Real‐world anti‐seizure treatment and adverse events among individuals living with drug‐resistant focal epilepsy in the United States J Mao, K Takahashi, M Cheng, C Xu, A Boca, Y Song, A Dandurand Epilepsia Open, 2024 | | 2024 |
| Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data JC Moser, S Bhatia, A Amin, AC Pavlick, KA Betts, EX Du, T Poretta, ... Cancer Immunology, Immunotherapy 73 (7), 116, 2024 | | 2024 |
| Treatment Outcomes and Healthcare Resource Utilization Among People Living with Focal Onset Epilepsy and Deemed to be Drug Resistant in Clinical Practices in the United States … J Mao, K Takahashi, M Cheng, C Xu, AE Boca, A Dandurand, Y Song Neurology 102 (17_supplement_1), 48, 2024 | | 2024 |
| Development of a web-based tool to estimate potential neighborhood-level increases in life expectancy through achievable reductions in deaths A Chandran, C Xu, J Gross, S Helleringer, D Phelan-Emrick, K Althoff APHA's 2020 VIRTUAL Annual Meeting and Expo (Oct. 24-28), 2020 | | 2020 |
